Skip to content

Clinical trials

Breast Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: Taiwan Clear all

355 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20021
20034
20044
20059
20067
20076
20088
200917
201011
20119
201213
20139
201416
201515
201611
201717
201826
201917
202020
202122
202222
202327
202422
202523
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed150
Unknown status63
Active, not recruiting54
Recruiting52
Terminated23
Withdrawn4
Not yet recruiting4
Enrolling by invitation3
Approved for marketing2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital40
Hoffmann-La Roche39
Novartis Pharmaceuticals27
AstraZeneca26
Eli Lilly and Company20
Pfizer14
Chang Gung Memorial Hospital11
China Medical University Hospital11
Merck Sharp & Dohme LLC7
Sanofi5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms355
Neoplasm Metastasis33
Neoplasms26
Carcinoma, Non-Small-Cell Lung16
Ovarian Neoplasms13
Triple Negative Breast Neoplasms13
Stomach Neoplasms12
Lung Neoplasms10
Colorectal Neoplasms9
Pancreatic Neoplasms9

Trials

Showing 76 to 100 of 355. Each trial links to its page on Pharma Observatory.

255 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.